Monday, October 27, 2025

Axis Mutual Fund Launches Axis Income Plus Arbitrage Passive FOF


An open-ended fund of funds scheme investing in passive debt oriented mutual fund schemes and arbitrage funds)

Axis Mutual Fund, one of India’s leading asset management companies, today announced the launch of the Axis Income Plus Arbitrage Passive FOF, an innovative open-ended scheme designed to offer investors a blend of stability, predictability, and tax efficiency. The New Fund Offer (NFO) will open for subscription on Oct 28, 2025, and close on Nov 11, 2025. The fund is managed by Devang Shah (Head – Fixed Income), Aditya Pagaria (Senior Fund Manager), Hardik Satra (Senior Fund Manager), and Karthik Kumar (Fund Manager).

 

This new offering is tailored for investors seeking to optimize their post-tax returns while maintaining a conservative risk profile. The fund strategically combines investments in passive debt-oriented mutual fund schemes with arbitrage funds, creating a hybrid structure that aims to deliver consistent returns over a medium-term horizon.

 

Commenting on the launch, B. Gopkumar, MD & CEO, Axis AMC said, “At Axis Mutual Fund, our focus has always been on delivering innovative, investor-centric solutions that combine performance with simplicity. The Axis Income Plus Arbitrage Passive FOF is a testament to this philosophy—offering a unique blend of stability, transparency, and tax efficiency. In a market where predictability and post-tax returns matter more than ever, this fund is designed to empower investors with a smarter way to approach fixed income investing.”

 

Key Highlights of Axis Income Plus Arbitrage Passive FOF

The scheme is structured to invest approximately 50–65% of its portfolio in passive debt-oriented mutual fund schemes, targeting high-quality - instruments. The underlying schemes would follow a roll-down strategy, which allows investors to benefit from accrual income while minimizing interest rate risk. The remaining 35–50% of the portfolio is allocated to arbitrage funds, which involve fully hedged equity positions. This component is designed to generate returns with minimal volatility, as it avoids directional market exposure. The combination of these two components ensures that the fund delivers debt-like returns with enhanced tax efficiency.

 

The scheme is benchmarked against a composite index comprising 65% NIFTY Short Duration Debt Index and 35% Nifty 50 Arbitrage TRI, reflecting its dual exposure. The fund offers high liquidity with T+2 redemption payouts and no exit load, making it a flexible option for investors. Additionally, the fund’s structure ensures no tax liability on rebalancing of the underlying schemes, further enhancing its efficiency.

 

Why Invest in Axis Income Plus Arbitrage Passive FOF

This fund is ideally suited for corporates, high-net-worth individuals (HNIs), and retail investors who are looking for a low to moderate risk investment that aims to offers fairly stable returns over a medium-term horizon. The use of passive roll-down strategies in the debt component provides visibility into returns when held to maturity, while the arbitrage allocation adds a layer of return enhancement with minimal incremental risk.

 

One of the most compelling reasons to invest in this fund is its tax efficiency. Unlike traditional debt mutual funds or fixed deposits, which are taxed at the investor’s slab rate, the Axis Income Plus Arbitrage Passive FOF qualifies for long-term capital gains (LTCG) taxation at just 12.5% if held for more than 24 months.

 

“With the current market environment offering attractive accrual opportunities and investors increasingly seeking tax-efficient alternatives to traditional fixed income products, the Axis Income Plus Arbitrage Passive FOF can be a timely solution,” said Ashish Gupta, CIO, Axis AMC. “By leveraging passive roll-down strategies and fully hedged arbitrage exposure, the fund is designed to offer a predictable and transparent investment experience.”

 

Moreover, the fund addresses key investor concerns—often referred to as the “5Ps”: Problem of Plenty, Predictability, Portfolio transparency, Post-tax returns, and Protection from credit events. By targeting to invest in a high-quality portfolio, the fund aims to minimize credit risk. Its passive structure aims for transparency and predictability, while the hybrid allocation model offers diversification and resilience across market cycles.

 

Source: RBI, Axis MF Research as on 10th Oct 2025 

 

Product Labelling & Riskometer: Axis Income Plus Arbitrage Passive FOF (an open-ended fund of funds scheme investing in passive debt oriented mutual fund schemes and arbitrage funds)

Please refer to SID for detailed Investment Strategy and other scheme related features available at axismf.com

 

About Axis AMC: Axis AMC is one of India`s fastest growing assets managers offering a comprehensive bouquet of asset management products across mutual funds (https://www.axismf.com/), portfolio management services and alternative investments (https://www.axisamc.com/homepage).

Responsive Unveils Fall 2025 AI Release To Help Enterprises Win Faster With Smarter, Trusted Knowledge


New AI Agents, an Enhanced Agent Studio, Content Health Dashboard, and Keyword Trends Help Organizations Democratize Knowledge Across Teams and Win More Business

 

Responsive, the leader in Strategic Response Management (SRM), today announced its Fall 2025 Release—introducing new AI agents, a no-code Agent Studio, and market intelligence tools designed to help global enterprises qualify, respond, and win faster. Building on over a decade of category leadership and $750B in managed opportunities, Responsive’s latest innovations give revenue teams the intelligence and agility to turn knowledge into a measurable growth advantage.

 

The release coincides with Responsive Summit 2025, where thousands of global customers will see the new capabilities in action.

 

"Knowledge only matters when everyone can access and trust it,” said Ginny Perrine-Wilson, Senior Manager, Global Bid and Proposal Management at Iron Mountain. “Responsive AI makes our expertise work harder for us. With new AI agents and capabilities like Executive Summaries and TRACE Score, our teams get what they need fast, tell better stories, and know every answer is solid. At the end of the day, that’s how we show up stronger and win more."

 

Responsive’s innovation is driven by deep collaboration with its customers. More than 100 leading enterprises—including Microsoft, EXL, Vodafone GmbH, Telefónica UK, and Tech Mahindra—have been early adopters of AI agents and capabilities released earlier this year, shaping the future of how organizations capture, share, and apply organizational knowledge and response intelligence to win business. 

 

Next generation AI agents built for every stage of the sales process 

 

The Responsive Fall 2025 Release expands the breadth of its out-of-the-box AI agents and introduces a more intuitive Agent Studio. Together, these advancements help organizations democratize knowledge by making trusted expertise accessible to every team. Buyers expect fast, personalized, and compliant answers, yet critical knowledge often lives in silos. Specialized agents allow frontline employees to access organizational knowledge to improve go/no-go decisions and deliver faster, more accurate responses - ultimately driving stronger outcomes.

 

Building on the Spring 2025 Release, which introduced the first AI agents purpose-built for SRM, the broader range and versatility of new agents allows revenue teams to accelerate their ability to qualify, respond, and win opportunities while harnessing deeper market and customer insight to improve positioning and differentiation. New capabilities include:

 

  • Fit Analysis Agent — Instantly reviews RFPs to surface key requirements, risks, and red flags, delivering a transparent fit score that helps teams qualify faster and focus on winnable opportunities.

 

  • Executive Summary Agent — Automatically crafts clear, compelling summaries that align proposals with buyer priorities—eliminating hours of manual editing.

 

  • Agent Studio — The next evolution of Responsive’s no-code environment that enables teams to design and deploy custom agents that analyse, interpret, and share insights -bringing strategy and decision intelligence into every pursuit.

Fuelling growth with trusted knowledge and market intelligence 

 

As more enterprises standardize on Responsive across sales, security, and compliance, one principle remains clear: AI is only as strong as the knowledge behind it. That knowledge includes both organizational expertise and market insight. 

 

Today, Responsive is introducing new capabilities that transform response data into a competitive advantage:

 

  • Content Health Dashboard gives organizations a clear, actionable view of their knowledge base, measuring accuracy, freshness, duplication, and compliance, and recommending improvements to keep knowledge trusted and response ready.

 

  • Keyword Trends unearths real-time market insight, surfacing emerging buyer priorities and demand signals based on questions buyers pose in bids and assessments - allowing revenue and product teams to adjust strategy and messaging in real time.

 

“Responsive has evolved from helping teams move faster to helping them work smarter,” said AJ Sunder, co-founder and Chief Product Officer at Responsive. “The enterprises that win are those that turn their knowledge and buyer insight into real intelligence that drives action.”

 

Responsive AI at scale: from adoption to impact

Adoption of Responsive AI has more than doubled year over year as customers move beyond experimentation to enterprise scale. Organizations are using Responsive AI to qualify faster, respond smarter, and accelerate revenue with measurable results, turning organizational knowledge into a measurable growth engine.

 

  • 45% of customer responses are AI-assisted, up from 7% last year

  • 46% of customers standardized on Responsive AI, up from 22%

  • 2x faster turnaround times and higher win rates reported by AI leaders

 

Expanding its global reach and impact, Responsive now serves 450,000+ users and 25% of the Fortune 100 across North America, Europe, APAC, and India. Recent expansion, including new offices in Coimbatore and Bengaluru and the acquisition of Australia-based Bidhive, reflects growing global demand for SRM innovation and Responsive’s continued category leadership.

 

About Responsive

Responsive is the global leader in Strategic Response Management (SRM), transforming how organizations share and exchange critical information. The AI-driven Responsive Platform is purpose-built to manage strategic responses at scale, empowering companies worldwide to accelerate growth, mitigate risk, and improve employee experiences. More than 2,000 companies have standardized on Responsive to manage RFPs, RFIs, DDQs, ESGs, security questionnaires, ad hoc requests, and more. Responsive is headquartered in Portland, Oregon, with offices in Kansas City, Missouri; Dallas, Texas; and Coimbatore, India. For more information, visit https://www.responsive.io.

Pregnancy-Associated Breast Cancer: Navigating Risk And Care In A Fragile Time

By Dr. Krunal Khobragade, Senior Consultant Surgical Oncology, HCG Cancer Center - Nagpur

When a woman discovers she is pregnant, her focus shifts to nurturing new life. Yet for a small number, cancer casts a shadow on that hope, breast cancer diagnosed during pregnancy or within a few years after childbirth. Known as pregnancy-associated breast cancer (PABC), this rare diagnosis poses unique challenges for both mother and child. As more women delay childbirth in India, understanding PABC’s risks, detection hurdles, treatment options, and emotional toll is vital. This article explores what the data tell us, and why timely care matters deeply.

Incidence and Risk Factors: A Rare, Rising Concern

PABC is uncommon, with estimates globally suggesting around 19.2 cases per 100,000 pregnancies in recent years. In India, precise figures remain elusive due to limited reporting, but single-centre registries place the incidence of PABC at about 0.6 % to 0.7 % of breast cancer cases. 

Despite its rarity, PABC carries disproportionate weight because it often strikes younger mothers, and diagnosis tends to be delayed. The risk is higher in women who give birth after age 30, those with a family history of breast cancer, or known genetic predispositions such as BRCA mutations. Parity and breastfeeding also modulate risk: in some cases, more pregnancies or longer breastfeeding may offer some protection, but this effect may be weaker in PABC’s biology.

Biological Characteristics: A More Aggressive Profile

PABC often differs from typical breast cancers in non-pregnant women. Tumors may show more aggressive behaviour: higher grade, more frequent lymph node involvement, and a tilt toward hormone receptor–negative or triple-negative subtypes. Pregnancy’s hormonal milieu, immune modulation, and the process of breast involution (post-lactation tissue remodelling) may contribute to faster progression. Because PABC tends to behave more aggressively, timely diagnosis and tailored treatment become all the more critical.

Diagnostic Challenges During Pregnancy and Postpartum

Diagnosing breast cancer during pregnancy or soon after is fraught with difficulty. Symptoms such as breast swelling, tenderness, nodularity or lumps are often dismissed as normal changes of pregnancy and lactation. This masking effect can delay detection. 

From an imaging perspective, mammography is limited (and must use abdominal shielding if employed). Ultrasound is safer and often the first choice; in select cases, MRI without contrast may be considered postpartum but is avoided during pregnancy. Biopsy (core needle) remains the gold standard for diagnosis even during pregnancy, with care to minimize foetal risk. 

Because delays in diagnosis often lead to more advanced disease at presentation, awareness among clinicians and patients is essential to minimize lost time.

Treatment Considerations and Approaches: Balancing Dual Lives

Treating PABC is a delicate balance between maternal welfare and foetal safety. A multidisciplinary team—involving oncologists, obstetricians, foetal medicine specialists, and paediatricians—must make decisions tailored to each case.

Surgery (mastectomy or breast-conserving where feasible) is generally safe in all trimesters. Axillary staging is also considered carefully. 

Chemotherapy can be administered safely in the second and third trimesters using regimens such as anthracyclines (e.g. doxorubicin) and taxanes. First-trimester use is avoided due to higher risk of miscarriage and foetal malformations. Radiotherapy is contraindicated during pregnancy and must be postponed until after delivery. Hormonal therapies and targeted agents like trastuzumab are deferred until postpartum due to foetal risks. 

After delivery, treatment intensifies as needed, targeted therapy, radiotherapy, hormonal therapy, and adjuvant chemotherapy become part of the postpartum plan.

Discussions about fertility preservation are important in postpartum scenarios, as cancer therapies may affect ovarian reserve. 

Crucially, the timing of intervention matters: delays to wait for delivery may worsen outcomes, so, whenever safe, therapy should begin without undue hesitation.

Prognosis and Outcomes: Challenges, but Not Without Hope

Historically, survival in PABC was thought to be worse than in non-pregnancy breast cancer. Some studies show increased risk of recurrence and mortality; others, when matched for stage and treatment, find similar outcomes. In an Indian cohort, three-year relapse-free survival was reported at around 40%, and overall survival at about 50%, underscoring the gravity of delayed detection and aggressive disease. 

Yet outcomes improve when diagnosis is early, treatment is immediate, and therapeutic decisions are well coordinated. Tailoring therapy to tumour subtype and stage can bring outcomes closer to those of non-pregnancy breast cancers.

Psychosocial Impact and Support Needs

A cancer diagnosis during pregnancy or early motherhood is emotionally wrenching. Women must reconcile fears for their health, their baby’s wellbeing, and the uncertainty ahead. The psychological burden is immense.

They need targeted counselling services that address anxieties about foetal effects, loss of fertility, breastfeeding decisions, and future pregnancies. Support groups specializing in PABC offer shared experience and emotional relief. Healthcare teams should adopt empathetic communication, offer clear explanations, and ensure psychological supports are in place from the start.

Conclusion: Safeguard Motherhood, Protect Lives

Pregnancy-associated breast cancer is rare, but for affected women, it presents complex risks and urgent decisions. Delays in diagnosis, more aggressive biology, and dual stakes for mother and child make its management uniquely challenging.

To change outcomes, India needs heightened awareness among women, obstetricians, and primary care doctors. Suspicious breast changes in pregnancy or postpartum must be promptly evaluated, never dismissed. Treatment protocols should be multidisciplinary, evidence-based, and individualized. Investment in research and support systems focused on this vulnerable group will pay life-changing dividends.

Let us commit, today to closer vigilance, timely care, and compassionate support. In safeguarding mothers, we protect generations to come

Kotak Mahindra Bank Announces Reappointment Of C.S. Rajan As Part-Time Chairman


Kotak Mahindra Bank Limited (KMBL or “Kotak” or “the Bank”) today announced that the Reserve Bank of India (RBI) has accorded its approval for the reappointment of Mr. C S Rajan, Independent Director on the Board of the Bank, as Part-Time Chairman for a further period from January 1, 2026 to October 21, 2027, in terms of Section 10(B)(1A)(i) of the Banking Regulation Act, 1949.

 

Mr. Ashok Vaswani, Managing Director & CEO, Kotak Mahindra Bank said: “Kotak Mahindra Bank stands at an exciting juncture of growth and transformation. As we navigate our next phase of growth, we look forward to Mr. Rajan’s continued leadership and strategic vision, which will help us deliver sustainable value to our stakeholders.”

 

Mr. C S Rajan, Part-Time Chairman, Kotak Mahindra Bank said: “I am honoured to continue serving as Chairman of Kotak Mahindra Bank. I look forward to working closely with the Board and management to further strengthen the Bank’s position and deliver value to all stakeholders.”

 

Mr. Rajan’s reappointment ensures continuity in leadership and governance as the Bank progresses on its strategic growth path. He has been serving as Part-Time Chairman since January 1, 2024, following RBI’s earlier approval for a two-year term.

 

Mr. Rajan a Post Graduate in History, is an accomplished leader with 46 years of experience in public life. He was appointed as an Independent Director on the Board of the Bank, with effect from October 22, 2022 and as Chairman, with effect from January 1, 2024. An IAS officer of the 1978 batch, Mr. Rajan retired as the Chief Secretary of the Government of Rajasthan in 2016. He served in leadership roles for 12 years in key Infrastructure sectors, such as, Energy, Highways, Water Resources and Industry, including SSI / MSME and enjoyed a long stint of 14 years in Agriculture and Rural Development. During his years as an IAS officer, he has also been exposed to the fields of Human Resources, Finance and General Administration. He has served on inter-disciplinary teams for review of World Bank Agriculture projects in other states and as a Consultant to the World Bank in a study on ‘Farmer Participation in Agricultural Research and Extension System’ which was later on published as a book co-authored by him.

 

After his retirement from active service in July 2016, Mr. Rajan served as Deputy Chairman in the Chief Minister of Rajasthan’s Advisory Council for a period of two and half years. In October 2018, Mr. Rajan was appointed by the Government of India on the Board of Infrastructure Leasing and Financial Services Limited ("IL&FS"), initially as Director from October 2018 to April 2019, thereafter as Managing Director from April 2019 to April 2022, then as Chairman & Managing Director from April 2022 to October 2022 and finally, as the Non-Executive Chairman of IL&FS from October 2022 until his resignation in September 2024. Mr. Rajan is also an Independent Director on the Board of Kotak Mahindra Life Insurance Company Limited, a wholly-owned subsidiary of the Bank.

 

About Kotak Mahindra Group

 

Established in 1985, Kotak Mahindra Group is one of India's leading financial services conglomerates. In February 2003, Kotak Mahindra Finance Ltd. (KMFL), the Group's flagship company, received banking license from the Reserve Bank of India (RBI), becoming the first non-banking finance company in India to convert into a bank - Kotak Mahindra Bank Ltd (KMBL).

 

Kotak Mahindra Group (Group) offers a wide range of financial services that encompass every sphere of life. From commercial banking, to stock broking, mutual funds, life and general insurance and investment banking, the Group caters to the diverse financial needs of individuals and the corporate sector. The premise of Kotak Mahindra Group’s business model is concentrated India, diversified financial services. The bold vision that underscores the Group’s growth is an inclusive one, with a host of products and services designed to address the needs of the unbanked and insufficiently banked.

 

Kotak Mahindra Group has a global presence through its subsidiaries in UK, USA, Gulf Region, Singapore and Mauritius with offices in London, New York, Dubai, Abu Dhabi, Singapore and Mauritius respectively. As on 30th September 2025, Kotak Mahindra Bank Ltd has a national footprint of 2,198 branches and 2,758 ATMs (incl. cash recyclers), and branches in GIFT City and DIFC (Dubai).

 

For more information, please visit the Company’s website at https://www.kotak.com/en/home.html 

5,000+ People, One Mission: Apollo Hospitals’ Stroke Awareness Run Rallies Bengaluru Ahead Of World Stroke Day

  

●        The event, inaugurated by Mr. Tejaswi Surya, Member of Parliament underscored the importance of recognizing stroke symptoms early and acting within the golden hour to save lives

 

Apollo Hospitals, Bengaluru, organized the Stroke Awareness Run & Walk at Kittur Rani Chennamma Stadium, Jayanagar, to mark World Stroke Day 2025 and raise awareness about recognizing early signs of stroke and acting within the golden hour. With the participation of 5000 + people, the event brought together citizens, healthcare professionals, and stroke survivors, to promote the message that stroke is preventable, treatable, and reversible if attended to in time. The event was inaugurated by Mr. Tejaswi Surya, Member of Parliament, Bengaluru South in the presence of Mr. Seemant Kumar Singh IPS, City Police Commissioner, Bengaluru, and Mr. C K Ramamurthy, MLA, Jayanagar.

 

Participants took part in a 10 km run and a 4.5 km Golden Hour Walk, symbolizing the importance of timely intervention and rapid response in stroke emergencies. The event highlighted that every minute counts when it comes to saving brain function and reducing disability after a stroke.

 

While inaugurating the event, Mr. Tejaswi Surya, Member of Parliament, Bangalore South, said “The Central government has placed strong emphasis on strengthening stroke management across the country by expanding dedicated stroke units, improving access to timely treatment, and advancing preventive care through initiatives like Ayushman Bharat. At the state level, initiatives such as this by Apollo Hospitals play a vital role in building a healthier and more informed community. Stroke remains a growing public health concern that calls for greater awareness and faster response at the community level. Events like these remind us that timely recognition and immediate medical attention can make all the difference to patient recovery and outcomes.”

 

Mr. Seemant Kumar Singh IPS, City Police Commissioner, Bengaluru said “Stroke is not only a medical condition, it is a community issue that demands awareness, timely action, and preventive responsibility. We often overlook our own health in the rush of daily life. Events like these serves as a reminder for us to investment in our safety and well-being. I appreciate Apollo Hospitals for leading this awareness movement and bringing the community together. Recognizing the early signs of stroke and seeking immediate help can save a life, prevent disability, and change outcomes. Let’s take the initiative to stay alert and active, and stand by each other when every minute counts.”

 

Speaking on the occasion, Dr. P Satischandra, Sr. Consultant & Advisor – Neurology, Apollo Hospitals, Jayanagar, said, “In India, stroke has emerged as one of the leading causes of mortality and long-term disability, affecting a large section of the population. Of particular concern is its increasing incidence among younger, working-age adults, primarily due to uncontrolled hypertension, diabetes, smoking, and sedentary lifestyles. Unlike a heart attack, the symptoms of a stroke are frequently overlooked or misinterpreted, resulting in critical delays in seeking treatment. Greater awareness and prompt action by recognizing early warning signs can significantly improve outcomes and save many lives”.

 

Mr. Akshay Oleti, CEO – Karnataka Region, Apollo Hospitals, said, “The Stroke Awareness Run & Walk reflects Apollo Hospital’s commitment to community health beyond hospital walls. Through this initiative, we aim to build an informed and responsive community where people can recognize early symptoms, act fast, and access timely care. Our goal is to ensure that no life is lost or permanently disabled because of delayed action.”

 

Dr. Yatheesh Govindaiah, Unit Head, Apollo Hospitals Jayanagar, said, “Managing stroke requires not just advanced infrastructure, but also coordination and readiness across the entire healthcare system. At Apollo Hospitals, we have established integrated stroke protocols that ensure patients receive rapid diagnosis, imaging, and treatment within the golden hour. Equally important is creating awareness so that people reach the hospital at the earliest sign of a stroke. Initiatives like this help bridge that crucial gap between awareness and timely action, ultimately improving patient survival and recovery.”

 

Dr. Suryanarayana Sharma, Senior Consultant Neurologist & Stroke Specialist, Apollo Hospitals, Bannerghatta, said, "Stroke is a medical emergency that requires immediate attention. Recognizing the signs and symptoms early can significantly improve treatment outcomes and save lives. As a neurologist, I've seen firsthand the impact of timely intervention in stroke cases. It's crucial that we spread awareness about the importance of acting within the golden hour to prevent long-term disability and reduce mortality rates."

 

Dr. Chinmay Nagesh, Senior Consultant, Neuro and Vascular Interventional Radiology, Apollo Speciality Hospitals, Jayanagar said "Strokes that occur because of a major blood vessel block are the most severe yet, potentially, also the most reversible. An advanced endovascular procedure called Mechanical Thrombectomy can open up the blocked vessel. When performed in the golden hours this can result in remarkable recovery. This procedure is performed by specialized Neurointerventionists and is available only in comprehensive stroke centres with dedicated neuro-cathlabs.”

 

Dr. Gurucharan Adoor Senior Consultant Consultant Neurology, Apollo Hospitals, Bannerghatta, said, "Early recognition of stroke symptoms is key to effective treatment. Timely intervention can significantly improve patient outcomes and reduce long-term disability. As a neurologist, I emphasize the importance of awareness and swift action in stroke care."

 

Dr. Krishna Chaitanya N, Consultant – Neurosurgery (Brain & Spine) and Dr. Ajay Herur, Senior Consultant in Minimal Access Neurosurgery, Apollo Hospitals, Jayanagar, said, "Stroke is a critical condition that requires swift and precise medical intervention. As a neurosurgeon, I emphasize the importance of timely treatment in minimizing brain damage and improving patient outcomes. Acting within the golden hour can make a significant difference in saving lives and preventing long-term disability."

 

Dr. Sundeep VK, Consultant Neurosurgeon and Spine Surgeon, Apollo Hospitals, Jayanagar, said, “A stroke can change a life in an instant, without warning. Yet its impact can be reduced when we stay alert, act quickly, and respond with compassion. Recognizing the early signs is vital. If a person’s face suddenly droops, their arm feels weak, or their speech becomes slurred, do not wait. Call for emergency medical help immediately. Every second matters. Prevention begins with the choices we make each day which includes staying active, keeping our blood pressure under control, and taking care of our heart and brain health. As a society, we can build a future where more lives are saved in time and fewer families face the lasting effects of stroke.”

 

India reports nearly 1.8 million new stroke cases each year, with a growing number affecting adults under 50. In response to this rising burden, Apollo Hospitals has been actively working to improve stroke outcomes through timely diagnosis, advanced emergency care, and sustained public awareness efforts. The hospital regularly conducts community outreach programs to help people recognize early warning signs and seek immediate medical attention.

Total Pageviews